C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 85 filers reported holding C4 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,556 | -77.9% | 5,591 | -58.4% | 0.00% | – |
| Q4 2022 | $79,267 | -27.3% | 13,435 | +8.7% | 0.00% | – |
| Q3 2022 | $109,000 | +26.7% | 12,363 | +9.0% | 0.00% | – |
| Q2 2022 | $86,000 | -53.5% | 11,346 | +49.5% | 0.00% | – |
| Q1 2022 | $185,000 | -24.5% | 7,591 | -0.3% | 0.00% | – |
| Q4 2021 | $245,000 | -22.7% | 7,615 | +7.4% | 0.00% | – |
| Q3 2021 | $317,000 | +83.2% | 7,091 | +55.1% | 0.00% | – |
| Q2 2021 | $173,000 | +332.5% | 4,571 | +317.8% | 0.00% | – |
| Q1 2021 | $40,000 | +5.3% | 1,094 | -3.9% | 0.00% | – |
| Q4 2020 | $38,000 | – | 1,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
| Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
| Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
| COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
| Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
| RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
| Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
| CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
| HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |